We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8751
Air Industries Group
AIRI
$12.5M
| $10K | ﹤0.01% |
+93
| New | +$9.38K |
2014 Q3
0 quarters
|
|
8752
CALL
DELISTED
Amedisys
AMED
| $10K | ﹤0.01% |
500
+100
| +25% | +$1.93K |
2013 Q2
5 quarters
|
|
8753
Amphastar Pharmaceuticals
AMPH
$1.09B
| $10K | ﹤0.01% |
+871
| New | +$9.07K |
2014 Q3
0 quarters
|
|
8754
CALL
Artivion
AORT
$1.12B
| $10K | ﹤0.01% |
+1,000
| New | +$9.8K |
2014 Q3
0 quarters
|
|
8755
Alpha Pro Tech
APT
$55.5M
| $10K | ﹤0.01% |
+3,109
| New | +$7.56K |
2014 Q3
0 quarters
|
|
8756
CALL
Ashland
ASH
$3.33B
| $10K | ﹤0.01% |
204
| – | – |
2013 Q2
5 quarters
|
|
8757
CALL
American Vanguard Corp
AVD
$31.9M
| $10K | ﹤0.01% |
900
+400
| +80% | +$5.15K |
2013 Q2
5 quarters
|
|
8758
CALL
Ballard Power Systems
BLDP
$544M
| $10K | ﹤0.01% |
3,000
-6,400
| -68% | -$24.1K |
2013 Q4
3 quarters
|
|
8759
Perspective Therapeutics
CATX
$136M
| $10K | ﹤0.01% |
605
+105
| +21% | +$2.6K |
2014 Q1
2 quarters
|
|
8760
CALL
Choice Hotels
CHH
$4.91B
| $10K | ﹤0.01% |
200
+100
| +100% | +$5.05K |
2014 Q2
1 quarter
|
|
8761
Crexendo
CXDO
$196M
| $10K | ﹤0.01% |
3,223
+261
| +9% | +$804 |
2013 Q2
5 quarters
|
|
8762
CALL
Dana Inc
DAN
$2.93B
| $10K | ﹤0.01% |
500
-1,300
| -72% | -$29.5K |
2013 Q2
5 quarters
|
|
8763
PUT
Delek US
DK
$4.3B
| $10K | ﹤0.01% |
+300
| New | +$9.6K |
2014 Q3
0 quarters
|
|
8764
Eason Technology Ltd
DXF
$845K
| – | – |
0
| – | – |
2013 Q2
5 quarters
|
|
8765
CALL
Euronet Worldwide
EEFT
$2.21B
| $10K | ﹤0.01% |
200
+100
| +100% | +$4.98K |
2014 Q2
1 quarter
|
|
8766
Vaalco Energy
EGY
$672M
| $10K | ﹤0.01% |
1,200
+1,100
| +1,100% | +$8.9K |
2014 Q2
1 quarter
|
|
8767
Eterna Therapeutics
ERNA
$2.32M
| – | – |
0
| – | – |
2013 Q2
5 quarters
|
|
8768
CALL
Edwards Lifesciences
EW
$52.3B
| $10K | ﹤0.01% |
600
| – | – |
2013 Q2
5 quarters
|
|
8769
Fluent
FLNT
$87.2M
| $10K | ﹤0.01% |
560
+248
| +79% | +$4.56K |
2013 Q4
3 quarters
|
|
8770
PUT
ProShares UltraShort Gold
GLL
$95.4M
| $10K | ﹤0.01% |
+25
| New | +$8.8K |
2014 Q3
0 quarters
|
|
8771
PUT
DELISTED
Heidrick & Struggles
HSII
| $10K | ﹤0.01% |
500
| – | – |
2014 Q2
1 quarter
|
|
8772
ImmuCell
ICCC
$93.2M
| $10K | ﹤0.01% |
1,962
+110
| +6% | +$514 |
2013 Q2
5 quarters
|
|
8773
Income Opportunity Realty Investors
IOR
$75.3M
| $10K | ﹤0.01% |
+1,706
| New | +$11.1K |
2014 Q3
0 quarters
|
|
8774
Kelly Services Class B
KELYB
$990M
| $10K | ﹤0.01% |
673
+198
| +42% | +$3.31K |
2013 Q2
5 quarters
|
|
8775
PUT
KRONOS Worldwide
KRO
$890M
| $10K | ﹤0.01% |
700
-300
| -30% | -$4.6K |
2014 Q2
1 quarter
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.